A citation-based method for searching scientific literature

Barbara M Norquist, Mark F Brady, Maria I Harrell, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Robert A Burger, Krishnansu S Tewari, Floor Backes, Robert S Mannel, Gretchen Glaser, Cheryl Bailey, Stephen Rubin, John Soper, Heather A Lankes, Nilsa C Ramirez, Mary Claire King, Michael J Birrer, Elizabeth M Swisher. Clin Cancer Res 2018
Times Cited: 77

Kathryn Alsop, Sian Fereday, Cliff Meldrum, Anna deFazio, Catherine Emmanuel, Joshy George, Alexander Dobrovic, Michael J Birrer, Penelope M Webb, Colin Stewart, Michael Friedlander, Stephen Fox, David Bowtell, Gillian Mitchell. J Clin Oncol 2012
Times Cited: 665

List of shared articles

Times cited

Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancers.
S Intidhar Labidi-Galy, Thibault de La Motte Rouge, Olfa Derbel, Anita Wolfer, Elsa Kalbacher, Timothée Olivier, Jean-Damien Combes, Ketty Heimgartner-Hu, Olivier Tredan, Hemerson Guevara,[...]. Gynecol Oncol 2019

Targeting homologous repair deficiency in breast and ovarian cancers: Biological pathways, preclinical and clinical data.
Elodie Chartron, Charles Theillet, Séverine Guiu, William Jacot. Crit Rev Oncol Hematol 2019

Germline and Somatic BRCA1/2 Mutations in 172 Chinese Women With Epithelial Ovarian Cancer.
Yan You, Lei Li, Junliang Lu, Huanwen Wu, Jing Wang, Jie Gao, Ming Wu, Zhiyong Liang. Front Oncol 2020

Deleterious somatic variants in 473 consecutive individuals with ovarian cancer: results of the observational AGO-TR1 study (NCT02222883).
Jan Hauke, Eric Hahnen, Stephanie Schneider, Alexander Reuss, Lisa Richters, Stefan Kommoss, André Heimbach, Frederik Marmé, Sandra Schmidt, Katharina Prieske,[...]. J Med Genet 2019

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.
Panagiotis A Konstantinopoulos, Barbara Norquist, Christina Lacchetti, Deborah Armstrong, Rachel N Grisham, Paul J Goodfellow, Elise C Kohn, Douglas A Levine, Joyce F Liu, Karen H Lu,[...]. J Clin Oncol 2020

Decision analysis for secondline maintenance treatment of platinum sensitive recurrent ovarian cancer: a review.
Rebecca Arend, Shannon Neville Westin, Robert L Coleman. Int J Gynecol Cancer 2020

Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma.
Peter G Rose, James J Java, Ritu Salani, Melissa A Geller, Angeles Alvarez Secord, Krishnansu S Tewari, David P Bender, David G Mutch, Michael L Friedlander, Linda Van Le,[...]. Obstet Gynecol 2019

Tailoring Ovarian Cancer Treatment: Implications of BRCA1/2 Mutations.
Ainhoa Madariaga, Stephanie Lheureux, Amit M Oza. Cancers (Basel) 2019

Population Screening for Inherited Predisposition to Breast and Ovarian Cancer.
Ranjit Manchanda, Sari Lieberman, Faiza Gaba, Amnon Lahad, Ephrat Levy-Lahad. Annu Rev Genomics Hum Genet 2020

Frequency of germline BRCA1/2 mutations and association with clinicopathological characteristics in Turkish women with epithelial ovarian cancer.
Veli Sunar, Vakkas Korkmaz, Vehap Topcu, Büşranur Cavdarli, Zafer Arik, Bülent Ozdal, Yaprak Engin Ustun. Asia Pac J Clin Oncol 2021

Prevalence of germline pathogenic BRCA1/2 variants in sequential epithelial ovarian cancer cases.
Robert D Morgan, George J Burghel, Nicola Flaum, Michael Bulman, Andrew R Clamp, Jurjees Hasan, Claire L Mitchell, Helene Schlecht, Emma R Woodward, Fiona I Lallo,[...]. J Med Genet 2019

Potential insights from population kinetic assessment of progression-free survival curves.
David J Stewart, Dominick Bosse, Andrew Robinson, Michael Ong, Michael Fung-Kee-Fung, Stephanie Brule, John F Hilton, Alberto Ocana. Crit Rev Oncol Hematol 2020

Clonal tumor mutations in homologous recombination genes predict favorable clinical outcome in ovarian cancer treated with platinum-based chemotherapy.
Shangyi Luo, Yajing Zhang, Yiran Yang, Shiwei Zhu, Wei Liu, Jiali Zhu, Xin Liang, Zedong Jiang, Shangqin Sun, Xiaobo Hou,[...]. Gynecol Oncol 2020

Biomarkers in ovarian cancer: To be or not to be.
Rebecca Arend, Alba Martinez, Tomasz Szul, Michael J Birrer. Cancer 2019

Olaparib maintenance for first-line treatment of ovarian cancer: will SOLO1 reset the standard of care?
Rowan E Miller, Shanthini M Crusz, Jonathan A Ledermann. Future Oncol 2019

Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance.
Rachel M Hurley, Cordelia D McGehee, Ksenija Nesic, Cristina Correia, Taylor M Weiskittel, Rebecca L Kelly, Annapoorna Venkatachalam, Xiaonan Hou, Nicholas M Pathoulas, X Wei Meng,[...]. NAR Cancer 2021

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
Kathleen Moore, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim, Ana Oaknin, Michael Friedlander, Alla Lisyanskaya, Anne Floquet, Alexandra Leary, Gabe S Sonke,[...]. N Engl J Med 2018

Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer.
Se Ik Kim, Maria Lee, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song. J Ovarian Res 2019

Tumor Testing for Somatic and Germline BRCA1/BRCA2 Variants in Ovarian Cancer Patients in the Context of Strong Founder Effects.
Ana Peixoto, Pedro Pinto, Joana Guerra, Manuela Pinheiro, Catarina Santos, Carla Pinto, Rui Santos, Carla Escudeiro, Carla Bartosch, Rita Canário,[...]. Front Oncol 2020